Diaz-Arocutipa Carlos, Benites-Moya Cesar Joel, Torres-Valencia Javier, Mehta Adhya, Vicent Lourdes
Unidad de Revisiones Sistemáticas y Meta-análisis (URSIGET), Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru.
Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
Clin Cardiol. 2025 Mar;48(3):e70067. doi: 10.1002/clc.70067.
To assess in-hospital outcomes in patients undergoing urgent versus non-urgent transcatheter mitral edge-to-edge repair (TEER).
We used the NIS database 2016-2019 to include admissions who underwent TEER. Inverse probability of treatment weighting (IPTW) was used to compare urgent versus non-urgent groups.
A total of 29 730 weighted admissions were included, of whom 21.6% were urgent admissions. Urgent admissions had a higher risk of in-hospital mortality (risk ratio [RR] 3.67, 95% confidence interval [CI] 2.39-5.62), cardiogenic shock (RR 4.95, 95% CI 3.73-6.57), intra-aortic balloon pump (RR 3.97, 95% CI 2.53-6.23), percutaneous ventricular assist device (RR 17.24, 95% CI 6.37-46.66), mechanical ventilation (RR 3.79, 95% CI 2.80-5.11), acute stroke (RR 2.56, 95% CI 1.32-4.97), in-hospital cardiac arrest (RR 2.25, 95% CI 1.08-4.69), major bleeding (RR 5.18, 95% CI 2.97-9.06), increased length of stay (6 vs. 2 days, p < 0.001), and higher total costs ($229 160 vs. $164 653, p < 0.01) compared to non-urgent admissions. There was no difference between both groups for renal replacement therapy and pericardial complication.
Our results suggest that urgent TEER implantation was associated with an increased risk of in-hospital death and other short-term complications.
评估接受紧急与非紧急经导管二尖瓣缘对缘修复术(TEER)患者的院内结局。
我们使用2016 - 2019年的国家住院患者样本(NIS)数据库纳入接受TEER的住院患者。采用治疗权重反概率(IPTW)来比较紧急组与非紧急组。
共纳入29730例加权住院患者,其中21.6%为紧急住院患者。与非紧急住院患者相比,紧急住院患者的院内死亡风险更高(风险比[RR] 3.67,95%置信区间[CI] 2.39 - 5.62)、心源性休克风险更高(RR 4.95,95% CI 3.73 - 6.57)、主动脉内球囊反搏风险更高(RR 3.97,95% CI 2.53 - 6.23)、经皮心室辅助装置风险更高(RR 17.24,95% CI 6.37 - 46.66)、机械通气风险更高(RR 3.79,95% CI 2.80 - 5.11)、急性卒中风险更高(RR 2.56,95% CI 1.32 - 4.97)、院内心脏骤停风险更高(RR 2.25,95% CI 1.08 - 4.69)、大出血风险更高(RR 5.18,95% CI 2.97 - 9.06)、住院时间延长(6天对2天,p < 0.001)以及总费用更高(229160美元对164653美元,p < 0.01)。两组在肾脏替代治疗和心包并发症方面无差异。
我们的结果表明,紧急TEER植入与院内死亡风险及其他短期并发症增加相关。